Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 4 1Phase 2 1

Status

Completed 3Terminated 1

Sponsor Class

OTHER 27INDUSTRY 4NIH 2NETWORK 1

Study Type

Interventional 4Observational 2

Sponsor

Cancer Type

Classical hematology 3Tumor-Agnostic 1Gastrointestinal 1

Conditions

Venous Thromboembolism 3Venous Thrombosis 2Pulmonary Embolism 2Neoplasms 2Gastrointestinal Neoplasms 1

Interventions

pembrolizumab 1019Carboplatin 959Paclitaxel 932Gemcitabine 793Cisplatin 748Docetaxel 682Bevacizumab 610Pemetrexed 502Nivolumab 486Cyclophosphamide 466Capecitabine 461Fluorouracil 417Dexamethasone 402Rituximab 372Oxaliplatin 347Injections 342atezolizumab 297Trastuzumab 297Leucovorin 286Cetuximab 282Irinotecan 266130-nm albumin-bound paclitaxel 252Prednisone 244Doxorubicin 240Ipilimumab 226Lenalidomide 220Fulvestrant 217fludarabine 214durvalumab 205Erlotinib Hydrochloride 188

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
INDUSTRY × Interventional × Dalteparin × Clear all
NCT05171075 2026-04-17

MAGNOLIA

Anthos Therapeutics, Inc.

Phase 3 Terminated
417 enrolled
Classical hematologyGastrointestinal

Gastrointestinal Neoplasms, Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

NCT00942968 2024-04-18

Evaluation of Dalteparin for Long-term (One Year) Treatment of Blood Clots in Subjects With Cancer

Pfizer

Phase 4 Completed
338 enrolled 21 charts
Tumor-Agnostic

Neoplasms

NCT00952380 2019-04-16

Fragmin for the Treatment of Acute VTE in Pediatric Cancer Patients

Pfizer

Phase 2 Completed
38 enrolled 30 charts
Classical hematology

Venous Thromboembolism

NCT02073682 2019-03-06

Cancer Venous Thromboembolism (VTE)

Daiichi Sankyo

Phase 3 Completed
1,046 enrolled 24 charts
Classical hematology

Neoplasms, Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡